| Name | Title | Contact Details |
|---|
We are dedicated to investing in highly innovative, early stage biotechnology companies. We are focused on supporting the development of novel therapeutics for unmet medical needs.
NUVO GROUP- Developing the Future of Pregnancy Nuvo Group is committed to transforming pregnancy care for a new generation. We are focused on developing wearable, sensor-based technologies that utilize big data analytics to drastically improve pregnancy healthcare on a global scale. PregSense™ Meet the next generation solution to prenatal monitoring. PregSense™ is the first and only all-in-one pregnancy monitoring designed for remote monitoring and continuous data collection. The wearable, multimodal and wireless platform simultaneously captures multiple data sets from both the mother and the fetus, providing more insights to doctors and a better experience for expecting mothers. Our Team Nuvo Group is made up of a diverse, global group of dedicated engineers, scientists and proud parents. Our experience in product design and compliance coupled with our passion for forging new advancements in technologies, big data, apps and cloud-based analytics makes us the ideal partner to drastically improve prenatal care on a global level.
Bioventus®Inc. (Nasdaq: BVS) develops Innovations for Active Healing and its mission is to make a difference by helping patients resume and enjoy active lives. The Company has products for pain treatment & joint preservation, restorative therapies and bone graft substitutes. Established in 2012, Bioventus is headquartered in Durham, NC. The company has more than 800 employees worldwide and its international headquarters is in Hoofddorp, The Netherlands. Bioventus also has offices in Memphis, TN, Valencia, CA, Hod Hasharon, Israel and Mississauga, Ontario, Canada. Bioventus works with patients, payers and health care providers throughout the world.
CryoLife`s mission is to partner with clinicians to restore health by delivering innovative technologies. CryoLife is one of the world`s leading medical device companies, providing preserved human tissues for cardiac and vascular surgeries, mechanical heart valves for aortic or mitral valve replacement, surgical adhesives and sealants, vascular grafts, and state-of-the-art technology and surgical training in adult and pediatric cardiovascular surgery. CryoLife is a pioneer and leader in processing, preserving and distributing human tissues, for use in cardiac and vascular surgeries. Founded in 1984, CryoLife was the first biomedical company to specialize in low temperature preservation of human heart valves used for complex cardiac reconstruction, primarily in children born with heart defects. Since the company`s inception, it is estimated that Cryolife has received tissues from over 145,000 donors and CryoLife products and tissues have been implanted in over 1 million patients worldwide. CryoLife is headquartered in Kennesaw, Georgia, with offices in Austin, Texas, Guildford, Surrey, UK, and Hechingen, Germany, as well as sales and marketing centers in Singapore, and representation in over 85 countries worldwide. The firm`s 1000+ employees hail from 11 countries and speak 17 languages. CryoLife`s staff includes numerous full-time physicians and Ph.D.s, with disciplines in chemical engineering, biomedical engineering, biochemistry, protein chemistry and organic chemistry. CryoLife is a public company and is traded on the New York Stock Exchange under the symbol CRY.
Through Total Spend Management solutions, Amerinet strategically partners with health care providers to improve operating margins by creating efficiencies, reducing costs and identifying new revenue s.